{"id":"W4362458336","doi":"10.1002/cam4.5862","title":"Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization","year":2023,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Toronto; St. Michael's Hospital; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Queen's University; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Ipilimumab; Medicine; Reimbursement; Population; Cost effectiveness; Cohort; Internal medicine; Clinical trial; Incremental cost-effectiveness ratio; Quality-adjusted life year; Oncology; Pediatrics; Health care; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00211089,0.0003477746,0.0003680433,0.0006401858,0.0003296008,0.0007667011,0.0006363856,0.0005300806,0.001333968],"category_scores_gemma":[0.004509869,0.0002921807,0.001578759,0.00116229,0.0002741994,0.0003671142,0.0004059913,0.0007116891,0.0001725166],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002737258,"about_ca_system_score_gemma":0.00138293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.09977687,"about_ca_topic_score_gemma":0.08637108,"domain_scores_codex":[0.9990647,0.0003302047,0.00008032395,0.0002173926,0.0001522163,0.0001551877],"domain_scores_gemma":[0.9976693,0.0004925285,0.001109195,0.0003276098,0.0001879162,0.0002134992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009612721,0.0001249004,0.9951256,0.00004105852,0.0008985576,0.0001355279,0.00007372245,0.0005253135,0.0001413718,0.00008319128,0.000365255,0.001524246],"study_design_scores_gemma":[0.0001358005,0.0002871956,0.9954253,0.00002468255,0.0004748009,0.0002519789,0.0001509605,0.002670954,0.00006603452,0.00006941344,0.0004299105,0.00001302095],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997629,0.0002769894,0.00009322621,0.00009053555,0.00000405457,0.00002481169,0.001710552,0.000002862645,0.0001680511],"genre_scores_gemma":[0.9987025,0.0001232812,0.00008725736,0.00002847469,0.000005275703,0.00001846177,0.0009602032,0.000001610866,0.00007292168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09977687,"threshold_uncertainty_score":0.1983922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5293046685244431,"score_gpt":0.5121395733399435,"score_spread":0.0171650951844996,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}